Currently, there are 108.90M common shares owned by the public and among those 52.84M shares have been available to trade.
The company’s stock has a 5-day price change of -6.43% and 13.30% over the past three months. FIHL shares are trading -9.32% year to date (YTD), with the 12-month market performance down to -5.52% lower. It has a 12-month low price of $14.17 and touched a high of $21.32 over the same period. FIHL has an average intraday trading volume of 632.04K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.49%, 0.91%, and -4.93% respectively.
Institutional ownership of Fidelis Insurance Holdings Ltd (NYSE: FIHL) shares accounts for 42.71% of the company’s 108.90M shares outstanding.
It has a market capitalization of $1.79B and a beta (3y monthly) value of 0.26. The earnings-per-share (ttm) stands at -$0.14. The company has a debt-to-equity ratio at 0.21. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.59% over the week and 1.63% over the month.
Analysts forecast that Fidelis Insurance Holdings Ltd (FIHL) will achieve an EPS of 0.81 for the current quarter, 0.76 for the next quarter and 3.69 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.59 while analysts give the company a high EPS estimate of 0.59. Comparatively, EPS for the current quarter was 0.54 a year ago. Earnings per share for the fiscal year are expected to increase by 84.86%, and 71.39% over the next financial year. EPS should grow at an annualized rate of 52.11% over the next five years, compared to -2.45% over the past 5-year period.
Looking at the support for the FIHL, a number of firms have released research notes about the stock. Goldman stated their Sell rating for the stock in a research note on January 08, 2025, with the firm’s price target at $21-$16. Goldman coverage for the Fidelis Insurance Holdings Ltd (FIHL) stock in a research note released on September 17, 2024 offered a Neutral rating with a price target of $18.50. Barclays was of a view on September 05, 2024 that the stock is Equal Weight, while Evercore ISI gave the stock In-line rating on July 17, 2024, issuing a price target of $19. JP Morgan on their part issued Neutral rating on January 08, 2024.
